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We propose a multi-dimensional strategy, associating immunodetection to a protein fractionating two-dimensional liquid
chromatography tool, for serological characterization of microbial antigens. The originality of such immunoproteomic approaches
resides in their application in large-scale studies for rapid serotyping of micro-organisms, evaluation of immunomes and could be
proposed in the development and monitoring of vaccines.
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nation of any proteomic technology with an immuno-
logical data presentation. Its development is vital in an
age where it is increasingly becoming urgent to identify
disease biomarkers and pathogenic target antigens for
the development of new drugs and vaccines. Among the
current proteomic techniques available (Steel et al.,
2005), 2-DE has often been chosen as the working tool
in immunoproteomic applications in combination with
Western-blot (Klade, 2002). In this context, two-Abbreviations: SERPA, Serological Proteome Analysis; 2DLC,
two-dimensional liquid chromatography; PF2D, Protein fractionating
two-dimensional system; 2-DE, two-dimensional gel electrophoresis;
MM, apparent molecular mass; MS/MS, tandem mass spectrometry
used for polypeptide micro-sequencing; pI, isoelectric point; 2D, two
dimension
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(Neverova and Van Eyk, 2005) could promote the rapid
development of this area of research owing to their high
potential for automation and flexibility at being
interfaced with gel or liquid array-based immunological
techniques and analytical systems such as tandem mass
spectrometry (MS/MS) (Yan et al., 2003).
Here, we propose an immunoproteomic strategy
associating an analytical protein fractionating 2DLC
tool (PF2D) to immunological techniques, for the rapid
characterisation of unknown antigens, immunogens and
sera. The characterisation of a serum taken after a
specific immunological response necessitates the estab-
lishment of its cognate antigenic repertoire. A multi-
dimensional strategy combining PF2D with immuno-
detection, called PF2D-SERPA (serological proteome
analysis), could hence be applied to characterize such a
repertoire on the basis of pI, hydrophobicity, antibody
reactivity and relative mass.
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to identify the antigenic target(s) of an anti-Bacillus
subtilis antibody 1Bs-5 (Fig. 2A). The first step in our
experimental scheme (Fig. 1A), involves the preparation
of a soluble protein lysate to be injected onto the PF2D
system. In our study, we used a PF2D system
(‘ProteomeLab PF2D’, Beckman Coulter) based on the
prototype of Lubman (Lubman et al., 2002). This fully
automated tool employs pI and relative hydrophobicity
as the two parameters for protein fractionation in the
first and second dimension respectively. Liquid fractions
obtained at the end of each dimension can be separately
analyzed by immuno-blot to locate the fraction(s) that
contain the antigen(s) of interest. Before performing the
2nd dimension separation, the fractions obtained after
1st dimension can be analyzed by several techniques; in
our case dot-blot and Western-blot.Fig. 1. Schematic representation of immunoproteomic applications of the
characterization (PF2D-SERPA) of unknown microbial antigens. (A) Antig
unknown antigen of a protein lysate. (B) Serological characterization is realiz
with the same attenuated/inactivated micro-organism.Dot-blot used in first-line as a protein array
provides a rapid and economical means of screening
large numbers of liquid fractions for immuno-reactiv-
ity and hence reduces the number of fractions to be
further analyzed. In our study, (Fig. 2B), it allowed us
to narrow down our window of analysis by selecting
from a total of 30 fractions, four fractions which in
Western-blot resulted in only one immuno-positive
fraction (Fig. 2C). This corresponded to a pI range of
4.72–5.02 and consisted of a single immuno-reactive
protein band of interest (MM∼35kDa). The higher
immuno-reactivity observed in dot-blot as compared to
Western-blot, could be due to differences in protein
conformation brought about by variations in denatur-
ation conditions: “partial” in dot-blot and “total” by
Laemmli denaturation (Laemmli, 1970) before West-
ern-blot. Also, the absence of protein separation in‘ProteomeLab PF2D’ for antigenic (i-PF2D-MS/MS) and serological
enic characterization is realized using an antibody directed against an
ed using serum of one or more individuals vaccinated (VA1 and VA2)
Fig. 3. (A) Western-blot and (B) Silver stain of antigenic fraction after
2nd dimension (Fr′). The target antigenic band was detected by
Western-blot (arrow) and excised from a silver-stained gel for
subsequent analysis by MS/MS.
Fig. 2. (A) Western-blot of Bacillus subtilis protein lysate using 1Bs-5
serum. (B) Immuno-reactivity of a partially purified polyclonal
antibody used on PF2D 1st dimension Bacillus subtilis lysate fractions,
in dot-blot and (C) in Western-blot.
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cases, result in different antibody–antigen specificity
reactions. Combining both dot and Western-blot
provides supplementary information regarding the
immuno-reactive properties of the antibody used vis-
à-vis the different biochemical folded states of the
target antigen.
In this way, 1st dimension antigenic fractions
revealed and characterized by pI, can be selected for
subsequent separation in 2nd dimension. The resulting
2nd dimension liquid fractions are systematically
examined by dot-blot and the antigenic fractions
revealed are characterized by relative hydrophobicity.
A Western-blot performed at this stage enhances the
resolution of the 2D fractionation by additionally
separating the antigenic fraction along the relative
mass.
In our case, we applied the above procedure to the 1st
dimension reactive fraction. By Western-blot, we
identified the antigenic 2nd dimension fraction (Fig.
3A) and by silver nitrate-staining of the SDS-PAGE gel,
used to further purify the 2D reactive fraction by
separating the proteins along their relative mass, we
isolated and excised the reactive antigen for non-
ambiguous peptide sequencing by LC-MS/MS (Fig.
3B). The silver-staining step after each dimension gave
us a good idea of the level of purity achieved after
fractionation. This step was crucial in order to increase
the reliability of MS/MS sequencing. The pI data and
relative hydrophobicity obtained from our 1st and 2nd
dimension and the apparent molecular mass data from
SDS-PAGE all contributed to the biochemical charac-
terization of the target antigen; the latter finally
identified, after isolation and sequencing of theprotein band of interest by MS/MS, as flagellin
(pI 4.97, nominal mass 32607Da; SwissProt accession
no. P02968).
To monitor public health, it is often necessary to
characterize and identify a full set of antigens such as
those targeted by an immune system (immunome) in a
pathology (Klade, 2002; Madoz-Gurpide et al., 2001).
In this field, techniques such as SERPA, have previously
demonstrated the powerful potential of combining 2-DE
with serology (Vytvytska et al., 2002). PF2D-SERPA
coupled to mass spectrometry, protein preparations of
pathogens can be rapidly resolved by 2D liquid
separation and immuno-reactivity of sera, derived for
example from healthy and pathogen-infected popula-
tions, can be tested by array and gel-based immunode-
tection. Several antigens can thus be characterized by
their pI, relative hydrophobicity and relative mass, with
an eventual identification by peptide sequencing, and
classified on the basis of their immuno-reactivity as
potential new vaccine candidates. In the PF2D-SERPA
strategy (Fig. 1B), we propose a method by which the
efficiency of a novel vaccine (multi-antigen targeting or
preparations of attenuated or inactivated pathogen,
commensal or opportunistic micro-organisms) can be
evaluated by testing sera from vaccinated individuals. In
Fig. 1B, vaccinated animals (VA1 and VA2), show
serum reactivity different for most antigens but similar
for others e.g. Fraction 3 and Fraction C in the
diagnostic array. In our laboratory, different rabbit sera
raised against B. subtilis, used as a model, were
developed and analyzed. Firstly, a B. subtilis protein
lysate was prepared, dosed and fractionated using our
PF2D system. The resulting liquid fractions were then
analyzed by Western-blot using sera from vaccinated
individuals. This step revealed the immunogenic frac-
tions that were then selected for separation on a silver
nitrate stained SDS-PAGE gel for subsequent peptide
sequencing by MS/MS. A particular serum derived after
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following its immunogenic pattern. Moreover, the
immunogens could in turn be characterized by pI,
hydrophobicity and relative mass. Characterizing sera,
derived from a number of vaccinated individuals, often
reveals different serotypes that may be indicative of
varying degrees of protection that a vaccine confers to a
heterologous population. During the testing phases of a
vaccine, it is indispensable to classify the different
serotypes and their distribution in the population in
order to evaluate the efficacy of a novel vaccine against
pathogenic immunogens (Kyaw et al., 2000). Further-
more, comparative immunomic studies could allow the
identification of commonly shared and most immuno-
reactive targets expressed by the pathogen agents for the
development of broadly protective vaccines. This
strategy could be a promising tool for the development
of well-adapted vaccines to rapidly evolving pathogenic
agents.
In conclusion, PF2D-SERPA and its variant i-
PF2D-MS/MS are immunoproteomic methods which
can be proposed for multi-dimensional serological
characterization of unknown microbial antigens. PF2D
systems complete the existing proteomic arsenal by
offering several advantageous features such as non-
laborious working procedures, versatility with regard
to other analytical techniques and automation. The
originality of integrating PF2D systems to immuno-
proteomic strategies resides in their application in
large-scale studies aiming to rapidly serotype micro-
organisms, evaluate immunomes and could be pro-
posed in the development and monitoring of a
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